Compare Agilent Technologies Inc (A) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Nvidia Corp — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Nvidia Corp trades at $217.75 (market cap $5.27T). The key difference: Nvidia Corp is far larger — about 125.5× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.69%). Which is the better fit depends on your goals.
| A | NVDA | |
|---|---|---|
Market Cap | $42.00B | $5.27T |
Sector | Health | Technology |
52-Week High | $157.20 | $235.75 |
52-Week Low | $110.24 | $165.17 |
Enterprise Value | $43.55B | $5.20T |
Dividend Yield | 0.69% | 0.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
NVIDIA (NVDA) trades at $217.48, down 2.89% over the past day, with a bullish technical outlook supported by moving averages and strong support at $215. The company reported robust revenue of $130.50B for 2025, with net income surging to $72.88B, and has consistently beaten earnings expectations in recent quarters, reflecting its dominant position in AI chip markets.
Outlook remains positive with a consensus price target of $325.86, implying significant upside, though risks include high valuation multiples and competitive pressures. Investor sentiment is buoyed by AI growth prospects, but the stock's high P/E of 33.32 warrants caution amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
